Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Tobacco Abstinence Syndrome
NCT01781234Phase 2Completed
- Start
- Aug 2013
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Generex Oral-lyn in Tobacco Withdrawal. Started Aug 2013; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
Tobacco Withdrawal
Beyond the preview
Go deeper on NCT01781234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781234.